Transcriptomics

Dataset Information

0

Immunological differences between primary and metastatic breast cancer

ABSTRACT: Little is known about how the immune microenvironment of breast cancer evolves during disease progression. The goal of this project was to examine immune gene mRNA expression in primary tumors (P) and metastatic lesions (M). The expression of 730 immune-related genes was measured using the Nanostring PanCancer Immune Gene Panel.

ORGANISM(S): Homo sapiens

PROVIDER: GSE102818 | GEO | 2018/08/20

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Comparison of gene expression profiles obtained from whole blood and peripheral blood mononuclear cells (PBMCs)
2019-12-17 | GSE132006 | GEO
Transcriptomics Programmed death 1 receptor blockade and immune-related gene expression profiling in non-small cell lung carcinoma, head and neck squamous cell carcinoma and melanoma
2017-05-15 | GSE93157 | GEO
Transcriptomics Transcriptional analysis of 12 breast cancer patients
2022-02-09 | GSE180370 | GEO
Transcriptomics Transcriptomic analysis of orthotopic pancreatic tumors treated by Axl inhibitor TP-0903 or combination with chemo/immunotherapy using the nCounter PanCancer Immune Profiling panel (Nanostring Technologies) [mouse]
2021-11-01 | GSE185110 | GEO
Transcriptomics Immune-Related Gene Expressions in EOC using Nanostring analysis
2020-04-10 | GSE148392 | GEO
Transcriptomics Immune profiling of lymph nodes drained to cold vs hot triple-negative breast tumors.
2024-07-29 | GSE272455 | GEO
Other NanoString PanCancer Immune Panel in Black and White Breast Cancer Patients in the Women's Circle of Health Study (WCHS)
2020-12-18 | GSE163418 | GEO
Transcriptomics B16-huCD20 tumors treated with 177Lu-TRT were subjected to multiplex analysis to study the tumor immune signature.
2022-04-02 | GSE199624 | GEO
Other Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric acute myeloid leukemia [Nanostring PanCancer IO 360]
2024-08-27 | GSE228481 | GEO
Other Consensus molecular subtypes as biomarkers of FU/FA maintenance therapy with or without panitumumab in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212).
2023-02-15 | GSE221953 | GEO